Skip to content

Actuate Therapeutics (ACTU) IPO deck

Actuate Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of difficult-to-treat cancers.

This post is for subscribers only

Subscribe

Already have an account? Sign In

Latest